Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The CHALO! 2.0 mHealth-Based Multilevel Intervention to Promote HIV Testing and Linkage-to-Care Among Men Who Have Sex with Men in Mumbai, India: Protocol for a Randomized Controlled Trial.
Chaudary J, Rawat S, Dange A, Golub SA, Kim RS, Chakrapani V, Mayer KH, Arnsten J, Patel VV. Chaudary J, et al. Among authors: chakrapani v. JMIR Res Protoc. 2024 Nov 5;13:e59873. doi: 10.2196/59873. JMIR Res Protoc. 2024. PMID: 39499921 Free PMC article. Clinical Trial.
An eHealth Intervention for Promoting COVID-19 Knowledge and Protective Behaviors and Reducing Pandemic Distress Among Sexual and Gender Minorities: Protocol for a Randomized Controlled Trial (#SafeHandsSafeHearts).
Newman PA, Chakrapani V, Williams C, Massaquoi N, Tepjan S, Roungprakhon S, Akkakanjanasupar P, Logie C, Rawat S. Newman PA, et al. Among authors: chakrapani v. JMIR Res Protoc. 2021 Dec 10;10(12):e34381. doi: 10.2196/34381. JMIR Res Protoc. 2021. PMID: 34726610 Free PMC article.
Acceptability, usability, and willingness to pay for HIV self-test kits distributed through community-based, PLHIV network-led and private practitioners models in India: Results from the STAR III Initiative.
Laxmeshwar C, Hegde A, Dange A, Mariyappan K, Soosai M, Mane S, Sivasubramanian M, Doddamane M, Mukherjee M, Shreenivas GS, Pardesi M, Jambhale V, Rao Pakkela V, Arumugam V, Rungta V, Bansal Y, Chaudary J, Yeldandi V, Periasamy M, Uthappa C, Chawla S, Upadhyaya S, Nyendak M, Chakrapani V, Godbole S, Verma V, Singh Kushwaha B, Das C, Rajan S, Kumar Puri A, Prasada Rao JVR, Bhatnagar T, Reddy DCS, Green K. Laxmeshwar C, et al. Among authors: chakrapani v. J Int AIDS Soc. 2024 Aug;27(8):e26348. doi: 10.1002/jia2.26348. J Int AIDS Soc. 2024. PMID: 39118294 Free PMC article.
Understanding the Acceptability of Broadly Neutralizing Antibodies for HIV Prevention Among At-Risk Populations and Feasibility Considerations for Product Introduction in India: Protocol for a Qualitative Study.
Mukherjee J, Rawat S, Ul Hadi S, Aggarwal P, Chakrapani V, Rath P, Manchi P, Aylur S, Malhotra S, Keane M, Gangaramany A. Mukherjee J, et al. Among authors: chakrapani v. JMIR Res Protoc. 2024 Feb 7;13:e47700. doi: 10.2196/47700. JMIR Res Protoc. 2024. PMID: 38324364 Free PMC article.
104 results